Baxter Pre-Tax Profit Margin 2010-2025 | BAX
Current and historical pre-tax profit margin for Baxter (BAX) from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Baxter pre-tax profit margin for the three months ending March 31, 2025 was .
| Baxter Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2025-03-31 |
$9.67B |
$-0.41B |
-4.22% |
| 2024-12-31 |
$10.64B |
$-0.29B |
-2.72% |
| 2024-09-30 |
$10.64B |
$0.28B |
2.58% |
| 2024-06-30 |
$10.54B |
$0.27B |
2.56% |
| 2024-03-31 |
$10.44B |
$0.34B |
3.30% |
| 2023-12-31 |
$10.36B |
$0.24B |
2.34% |
| 2023-09-30 |
$8.97B |
$-0.62B |
-6.93% |
| 2023-06-30 |
$9.98B |
$-3.73B |
-37.39% |
| 2023-03-31 |
$9.86B |
$-3.33B |
-33.74% |
| 2022-12-31 |
$10.06B |
$-3.25B |
-32.30% |
| 2022-09-30 |
$13.79B |
$-2.81B |
-20.38% |
| 2022-06-30 |
$13.40B |
$0.69B |
5.12% |
| 2022-03-31 |
$12.91B |
$0.86B |
6.66% |
| 2021-12-31 |
$12.15B |
$1.12B |
9.19% |
| 2021-09-30 |
$12.45B |
$1.40B |
11.28% |
| 2021-06-30 |
$12.20B |
$1.37B |
11.22% |
| 2021-03-31 |
$11.82B |
$1.27B |
10.70% |
| 2020-12-31 |
$11.67B |
$1.29B |
11.07% |
| 2020-09-30 |
$11.53B |
$0.86B |
7.45% |
| 2020-06-30 |
$11.41B |
$0.93B |
8.11% |
| 2020-03-31 |
$11.53B |
$0.96B |
8.35% |
| 2019-12-31 |
$11.36B |
$0.97B |
8.54% |
| 2019-09-30 |
$11.14B |
$1.60B |
14.32% |
| 2019-06-30 |
$11.05B |
$1.49B |
13.45% |
| 2019-03-31 |
$11.06B |
$1.57B |
14.15% |
| 2018-12-31 |
$11.10B |
$1.62B |
14.57% |
| 2018-09-30 |
$11.08B |
$1.39B |
12.55% |
| 2018-06-30 |
$11.02B |
$1.31B |
11.87% |
| 2018-03-31 |
$10.79B |
$1.21B |
11.22% |
| 2017-12-31 |
$10.58B |
$1.10B |
10.39% |
| 2017-09-30 |
$10.43B |
$1.20B |
11.53% |
| 2017-06-30 |
$10.28B |
$1.04B |
10.12% |
| 2017-03-31 |
$10.26B |
$1.95B |
19.03% |
| 2016-12-31 |
$10.16B |
$4.95B |
48.75% |
| 2016-09-30 |
$10.12B |
$4.88B |
48.22% |
| 2016-06-30 |
$10.05B |
$4.72B |
46.96% |
| 2016-03-31 |
$9.94B |
$3.61B |
36.31% |
| 2015-12-31 |
$9.97B |
$0.43B |
4.29% |
| 2015-09-30 |
$10.15B |
$0.33B |
3.27% |
| 2015-06-30 |
$10.38B |
$0.57B |
5.46% |
| 2015-03-31 |
$12.06B |
$1.06B |
8.80% |
| 2014-12-31 |
$13.50B |
$1.57B |
11.60% |
| 2014-09-30 |
$15.03B |
$1.98B |
13.18% |
| 2014-06-30 |
$16.03B |
$2.44B |
15.24% |
| 2014-03-31 |
$15.55B |
$2.58B |
16.62% |
| 2013-12-31 |
$15.15B |
$2.62B |
17.32% |
| 2013-09-30 |
$14.33B |
$2.62B |
18.31% |
| 2013-06-30 |
$14.09B |
$2.73B |
19.34% |
| 2013-03-31 |
$14.00B |
$2.80B |
20.00% |
| 2012-12-31 |
$13.94B |
$2.84B |
20.36% |
| 2012-09-30 |
$14.03B |
$2.86B |
20.40% |
| 2012-06-30 |
$14.03B |
$2.82B |
20.12% |
| 2012-03-31 |
$14.00B |
$2.81B |
20.08% |
| 2011-12-31 |
$13.89B |
$2.81B |
20.22% |
| 2011-09-30 |
$13.80B |
$2.73B |
19.77% |
| 2011-06-30 |
$13.54B |
$2.64B |
19.51% |
| 2011-03-31 |
$13.20B |
$2.51B |
19.01% |
| 2010-12-31 |
$12.84B |
$1.89B |
14.72% |
| 2010-09-30 |
$12.82B |
$2.14B |
16.68% |
| 2010-06-30 |
$12.74B |
$2.16B |
16.92% |
| 2010-03-31 |
$12.67B |
$2.21B |
17.44% |
| 2009-12-31 |
$12.56B |
$2.73B |
21.76% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$15.731B |
$10.636B |
|
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
|
